Average Co-Inventor Count = 5.45
ph-index = 16
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (44 from 3,684 patents)
2. Bristol Meyers Squibb Company (1 from 41 patents)
45 patents:
1. 12247058 - Nucleic acids encoding modified FGF-21 polypeptides, vectors and cells containing, and use thereof
2. 11858979 - Fibronectin based scaffold domain proteins that bind PCSK9
3. 11408093 - Fibronectin binding domains with reduced immunogenicity
4. 11279751 - Fibronectin binding domains with reduced immunogenicity
5. 11248031 - Methods of treating diseases associated with fibrosis using modified FGF-21 polypeptides
6. 11203630 - Serum albumin-binding fibronectin type III domains
7. 11161893 - Fibronectin based scaffold proteins having improved stability
8. 11149077 - Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including IGF-IR
9. 10954286 - Bispecific EGFR/IGFIR binding molecules
10. 10947297 - Fibronectin based scaffold domain proteins that bind PCSK9
11. 10934572 - Serum albumin binding molecules
12. 10781247 - Targeted therapeutics based on engineered proteins that bind EGFR
13. 10774130 - Method of treating cancer by administering multivalent fibronectin based scaffold domain proteins
14. 10604556 - Fibronectin binding domains with reduced immunogenicity
15. 10464995 - Fibronectin binding domains with reduced immunogenicity